These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23470074)

  • 1. Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease.
    Anatoliotakis N; Deftereos S; Bouras G; Giannopoulos G; Tsounis D; Angelidis C; Kaoukis A; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):115-38. PubMed ID: 23470074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease.
    Ndrepepa G
    Clin Chim Acta; 2019 Jun; 493():36-51. PubMed ID: 30797769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase and coronary arterial disease: from research to clinical practice.
    Roman RM; Wendland AE; Polanczyk CA
    Arq Bras Cardiol; 2008 Jul; 91(1):e11-9. PubMed ID: 18660935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease.
    Maiocchi SL; Ku J; Thai T; Chan E; Rees MD; Thomas SR
    Pharmacol Ther; 2021 May; 221():107711. PubMed ID: 33137376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure.
    La Rocca G; Di Stefano A; Eleuteri E; Anzalone R; Magno F; Corrao S; Loria T; Martorana A; Di Gangi C; Colombo M; Sansone F; Patanè F; Farina F; Rinaldi M; Cappello F; Giannuzzi P; Zummo G
    Basic Res Cardiol; 2009 May; 104(3):307-20. PubMed ID: 19030913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction.
    Patterson EK; Fraser DD; Capretta A; Potter RF; Cepinskas G
    Free Radic Biol Med; 2014 May; 70():167-73. PubMed ID: 24583458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase and its contributory role in inflammatory vascular disease.
    Lau D; Baldus S
    Pharmacol Ther; 2006 Jul; 111(1):16-26. PubMed ID: 16476484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase As a Multifaceted Target for Cardiovascular Protection.
    Ramachandra CJA; Ja KPMM; Chua J; Cong S; Shim W; Hausenloy DJ
    Antioxid Redox Signal; 2020 May; 32(15):1135-1149. PubMed ID: 31847538
    [No Abstract]   [Full Text] [Related]  

  • 9. The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.
    Teng N; Maghzal GJ; Talib J; Rashid I; Lau AK; Stocker R
    Redox Rep; 2017 Mar; 22(2):51-73. PubMed ID: 27884085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment.
    Brennan ML; Hazen SL
    Curr Opin Lipidol; 2003 Aug; 14(4):353-9. PubMed ID: 12865732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia and oxidative stress strengthen the association between myeloperoxidase and blood pressure.
    Van der Zwan LP; Scheffer PG; Dekker JM; Stehouwer CD; Heine RJ; Teerlink T
    Hypertension; 2010 Jun; 55(6):1366-72. PubMed ID: 20385972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
    Heslop CL; Frohlich JJ; Hill JS
    J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease.
    Nussbaum C; Klinke A; Adam M; Baldus S; Sperandio M
    Antioxid Redox Signal; 2013 Feb; 18(6):692-713. PubMed ID: 22823200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of leukocyte-generated oxidants in left ventricular remodeling.
    Penn MS
    Am J Cardiol; 2008 May; 101(10A):30D-33D. PubMed ID: 18474271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
    Maruyama Y; Lindholm B; Stenvinkel P
    J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of physical exercise on endothelial function, indicators of inflammation and oxidative stress].
    Skrypnik D; Bogdański P; Madry E; Pupek-Musialik D; Walkowiak J
    Pol Merkur Lekarski; 2014 Feb; 36(212):117-21. PubMed ID: 24720109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cells serve as intravascular carriers of myeloperoxidase.
    Adam M; Gajdova S; Kolarova H; Kubala L; Lau D; Geisler A; Ravekes T; Rudolph V; Tsao PS; Blankenberg S; Baldus S; Klinke A
    J Mol Cell Cardiol; 2014 Sep; 74():353-63. PubMed ID: 24976018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
    Schindhelm RK; van der Zwan LP; Teerlink T; Scheffer PG
    Clin Chem; 2009 Aug; 55(8):1462-70. PubMed ID: 19556446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of myeloperoxidase as a risk marker for atherosclerosis.
    Nambi V
    Curr Atheroscler Rep; 2005 Mar; 7(2):127-31. PubMed ID: 15727728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.